Contents

Disclaimer

Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breastfeeding.

Show Summary Details
Page of

Investigation of the slowly growing child 

Investigation of the slowly growing child
Chapter:
Investigation of the slowly growing child
Author(s):

L. Patel

and P. E. Clayton

DOI:
10.1093/med/9780199235292.003.7057
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 18 June 2019

Reduced height velocity for age and stage of puberty implies slow growth. Although this occurs independently from actual height, children identified for investigation tend to be the ones who are slowly growing, as well as short. The majority of short slowly growing children do not have a recognized endocrinopathy. The commonest growth disorders are those grouped under the heading ‘idiopathic’, which includes constitutional delay in growth and puberty, a disorder of the tempo of maturation, and familial/genetic short stature. These children present with short stature, an unremarkable phenotype, and a variable extent of growth failure. The challenge to the clinician is to differentiate these children from those who may have a defined nonendocrine pathology (for example, chronic systemic disease (Box 7.2.4.1), bone disorder, or psychosocial problem) and those who may have an abnormality within the growth hormone axis.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.